Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging.
about
Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR ImagingClinical and research applications of simultaneous positron emission tomography and MRIModern brain tumor imagingPerfusion MR imaging in gliomas: comparison with histologic tumor gradePerfusion MRI: the five most frequently asked clinical questions.Magnetic resonance perfusion imaging in neuro-oncology.Pseudoprogression of glioblastoma after chemo- and radiation therapy: diagnosis by using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging with ferumoxytol versus gadoteridol and correlation with survival.Three-dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement.Pseudoprogression in patients with glioblastoma: added value of arterial spin labeling to dynamic susceptibility contrast perfusion MR imaging.Diagnosis and management of astrocytomas, oligodendrogliomas and mixed gliomas: a review.Diffusion imaging for tumor grading of supratentorial brain tumors in the first year of life.Discrimination between glioma grades II and III in suspected low-grade gliomas using dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging: a histogram analysis approach.Molecular Imaging Using Endogenous Cellular Proteins.Benefits of dynamic susceptibility-weighted contrast-enhanced perfusion MRI for glioma diagnosis and therapy.[Perfusion measurement using the T2* contrast media dynamics in neuro-oncology. Physical basics and clinical applications]ASFNR recommendations for clinical performance of MR dynamic susceptibility contrast perfusion imaging of the brain.Differentiating surgical from non-surgical lesions using perfusion MR imaging and proton MR spectroscopic imaging.Update on brain tumor imaging.Angiogenesis in gliomas: imaging and experimental therapeutics.Double-echo perfusion-weighted MR imaging: basic concepts and application in brain tumors for the assessment of tumor blood volume and vascular permeability.Brain MRI: tumor evaluation.Comparison of cerebral blood volume maps generated from T2* and T1 weighted MRI data in intra-axial cerebral tumours.Advanced MRI manifestations of trigeminal ganglioneuroma: a case report and literature review.A prospective study on the added value of pulsed arterial spin-labeling and apparent diffusion coefficients in the grading of gliomas.Neuro MR: protocols.Improving lesion detection and visualization: implications for neurosurgical planning and follow-up.The role of advanced MR imaging in understanding brain tumour pathology.Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumorsTumours.Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a reviewDifferentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imagingGlioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imagingMR imaging of high-grade brain tumors using endogenous protein and peptide-based contrast.High-relaxivity contrast-enhanced magnetic resonance neuroimaging: a review.Functional MRI for radiotherapy of gliomas.Integrating diffusion kurtosis imaging, dynamic susceptibility-weighted contrast-enhanced MRI, and short echo time chemical shift imaging for grading gliomas.Analysis of metabolic indices in regions of abnormal perfusion in patients with high-grade glioma.Neuroradiological viewpoint on the diagnostics of space-occupying brain lesions.MR-visible lipids and the tumor microenvironmentAssessment of therapeutic response and treatment planning for brain tumors using metabolic and physiological MRI.
P2860
Q26796223-0B589163-20C3-4134-A583-EDC95F0B22CFQ26998774-12AB7329-278C-4752-A1F5-170C109EE9DFQ27002344-908E8C72-29C7-4EE2-9AD4-EE9110FD359EQ28344008-C69B68B0-452E-408B-A5CB-9868D9DE5C36Q30416198-8211C72C-C04A-40D8-91AC-9FABA5962EADQ30479156-FE738D7F-A375-498A-8189-885862096B09Q30579847-78DB7076-EF33-43F9-A899-96A2DDED7C5AQ30594301-701FDB0C-CECC-4142-BB81-F749A022A9B2Q30617625-E7DAE673-A4C6-4413-8E06-DAE0ECCDD3D3Q30680698-789F8AD6-514D-4A2B-A8FA-3D9DED09A05EQ30690399-55373AAC-6BE2-4671-B264-3D60AE437097Q30849400-1FC554D7-0F2F-4C71-87C4-41960FF65A2EQ30856242-77614272-A0F2-4C85-B7DE-59EDCE928786Q30872679-0166D72F-73E0-4112-A047-330B5734F6EEQ30923784-6B9A2C7B-7B07-46E9-AFC9-4F3027A58F1EQ30938805-6E9B1722-6D8B-4EC0-BB51-982E1C5C5F16Q30976984-3D75C728-EE11-4916-90DD-62AC8C00CB98Q30988699-708A7D4B-9AC5-4863-AD17-DDC6FF40F5A2Q31028310-0C1CD430-3CDC-4692-BE95-07133434A218Q31029129-CA073E86-11F5-4910-9B5E-2694910E2BDAQ31059424-70F27042-5374-47FB-A84B-AC1F4B34C3E9Q31101076-42CAA7B2-C876-466B-BD84-F4DE504A9444Q31125548-2F84FF05-31BD-4AEE-91CC-4EDA0E11B4FCQ31130548-1DB36148-9425-4AE1-9CA4-52038C47144CQ31131106-569F005B-9C7F-46C8-91F5-8489553003F3Q33292588-4C245603-0201-4C8E-84DA-F38B3BFC136CQ33309683-186DE265-1A62-43EC-94B5-EDDB8C571C93Q33368027-0C7434CE-A83D-47E9-B4E7-FD672B746C30Q33378556-7B79F2CB-2993-46E1-820D-2B0ECDC8FE6BQ33503551-4E91B169-BEB6-4613-8CCA-FED42D74414EQ33507482-C92DAEC5-3323-4578-AD90-48F45BD65C6EQ33525779-D0B50A28-6C33-4841-A201-C9B1ACF19402Q33534946-FD4D96DC-8059-4ECF-B69E-1E417A2AD1D4Q33612406-3B02C26A-4167-4722-BE8C-F38864C0759FQ33631456-6A5C5592-25DF-4BBC-B800-1E404D20BCBEQ33753445-9F031942-B1A7-4FC4-8D20-13FE255EB469Q33793833-CF6E8FA8-E5B7-462B-9DFC-7569551F9EEFQ33888131-1C5CBA3C-7425-42E6-8932-1D1A74727D5BQ33888362-62C37DD4-5D49-41B9-8263-5412583ACFEEQ33888366-62AF05E4-6AF9-4F26-A930-6F97920975A1
P2860
Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging.
@en
Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging.
@nl
type
label
Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging.
@en
Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging.
@nl
prefLabel
Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging.
@en
Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging.
@nl
P2093
P1433
P1476
Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging.
@en
P2093
Golfinos JG
Kricheff II
Mazumdar A
P304
P356
10.1148/RADIOLOGY.211.3.R99JN46791
P407
P50
P577
1999-06-01T00:00:00Z